Y. Komatsu

发表

Treatment of a Gilbert's Syndrome Patient with Irinotecan, Leucovorin and 5-Fluorouracil

M. Asaka, H. Takeda, S. Yuki, 2005, Journal of chemotherapy.

Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer

K. Muro, M. Tajika, H. Yasui, 2021, ESMO open.

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer

J. Furuse, I. Hyodo, M. Takeuchi, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

O-21 METABEAM study: Combined analysis of concordance studies between liquid and tissue biopsies for RAS mutations in colorectal cancer patients with single metastatic sites

E. Oki, T. Yamanaka, J. Tabernero, 2020 .

VOLTAGE: Multicenter phase Ib/II study of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy (CRT) with capecitabine in patients with locally advanced rectal cancer (LARC).

A. Sato, M. Kojima, T. Yoshino, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase 3 trial.

A. Sawaki, Y. Kurokawa, Y. Honma, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

TRIUMPH: Primary efficacy of a phase II trial of trastuzumab (T) and pertuzumab (P) in patients (pts) with metastatic colorectal cancer (mCRC) with HER2 (ERBB2) amplification (amp) in tumour tissue or circulating tumour DNA (ctDNA): A GOZILA sub-study

Yusuke Nakamura, S. Nomura, J. Odegaard, 2019, Annals of Oncology.

80P Blood tumor mutational burden (bTMB) and efficacy of immune checkpoint inhibitors (ICIs) in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN

E. Oki, E. Sokol, D. Fabrizio, 2021, Annals of Oncology.

Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC)

J. Furuse, M. Ikeda, K. Sugimori, 2019, Annals of Oncology.

SO-37 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504)

Mamoru Ito, M. Kojima, T. Yoshino, 2020 .

REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis.

E. Oki, T. Yamanaka, J. Furuse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

1513MO A phase II study of nivolumab plus low dose ipilimumab as first -line therapy in patients with advanced gastric or esophago-gastric junction MSI-H tumor: First results of the NO LIMIT study (WJOG13320G/CA209-7W7)

Y. Komatsu, M. Tsuda, N. Sugimoto, 2023, Annals of Oncology.